News Articles

Health 07 Nov 2022

Healthtech banks on rising numbers

The commercial side of life sciences may have reached a critical mass in WA.

News 16 Jun 2022

Entrepreneurial trio keen for more

Tony Grist, Gavin Rezos and Stephen Langsford are prolific dealmakers - they share the lessons they've learned over three decades and explain what they look for in new investments.

Special Reports 28 Apr 2020

Major pandemic role for medtech

SPECIAL REPORT: As markets struggle under the pressure of the COVID-19 pandemic, the medtech industry has found itself with an unparalleled, if challenging, opportunity.

Special Reports 28 Apr 2020

Research skills not matched by returns

SPECIAL REPORT: Despite WA's history of innovative medical research, the state's medtech sector continues to grapple with outsider perceptions and its own commercial direction.

Appointments 22 Feb 2016

Board Moves Feb 17-22 2016

Ardiden has appointed Bradley Boyle as executive director and Michael Stares as general manager – Canadian operations. Mr Boyle was formerly a managing director of Triton Minerals.

Deals 08 Jan 2016

pSivida to raise $US16m

US-focused biotech company pSivida has released pricing details of a $US16 million capital raising, after two weeks of volatile trading in its ASX-listed shares.

Professions 21 Dec 2015

Tech vets lead new direction for deals

Experienced investors such as Gavin Rezos and Tony Grist have shone brightly as the technology sector has attracted growing interest.

Special Reports 13 Jul 2015

Alexium on familiar pathway to market

Momentum is building for Alexium, after the award-winning tech developer initially struggled to find its feet.

Technology, Innovation & Science 19 Dec 2013

pSivida surges on regulatory news

Shares in biotech company pSivida Corp surged more than 50 per cent today on positive regulatory news from the United States, making up most of the losses it suffered in a dramatic fall in October.

Opinion 08 Nov 2013

Bitter pill for investors’ pain

Investing in the share market is an inexact science, and biotech stocks can add a further layer of complexity to the formula.

20 Jan 2011

pSivida to raise $US10m

Global drug delivery company, pSivida, has launched a $10 million capital raising, proceeds from which it says will be used for general corporate purposes.

Food & Drink 21 Jan 2008

pSivida sells subsidiary for $5.9m

Perth-based biotechnology company pSivida Ltd has sold its food science subsidiary pSiNutria to UK-based venture capital group, Intrinsiq Materials Cayman Ltd, in a deal worth about US$5.18 million ($5.9 million).

22 Aug 2007

pSivida opens enrolments for macular edema treatment trials

Perth-based biotechnology company pSivida Ltd has commenced enrolment for the first studies of absorption, distribution and metabolism of its diabetic macular edema treatment Medidur, the company has announced.

06 Jul 2007

pSivida raises $12.5m in first tranche of ADS sale

Perth-headquartered bio-nanotech company pSivida Ltd has closed the first tranche of its $21.3 million American Depository Shares and warrants sale, raising $12.5 million through the sale of 9.2 million units.

13 Apr 2007

pSivida sells AION Diagnostics for $3.6m

Perth-headquartered bio-nanotech company pSivida Ltd has sold its subsidiary AION Diagnostics Inc to US-based private equity group GEM Global Yield Fund for around $3.6 million, following the company's float on the Frankfurt Stock Exchange.

05 Apr 2007

pSivida raises $11m in placement for loan repayment

Perth-based biotechnology company pSivida Ltd will raise around $11 million through a placement to pay off a convertible note debt, one day after receiving a promise from collaborative partner Pfizer Inc for a further $6.1 million share purchase.

04 Apr 2007

pSivida signs $203m research deal with Pfizer

Perth-based biotechnology company pSivida Ltd has signed a collaborative research and license agreement with pharmaceutical giant Pfizer Inc worth $203 million for its drug delivery technologies.

19 Feb 2007

pSivida to raise $11.5m in placement as Nordic SPV in doubt

Perth-based biotechnology company pSivida Ltd will raise $11.5 million through a placement to raise funds for working capital in place of a proposed $5.1 million interim investment from Danish group Nordic Biotech Advisors.

10 Nov 2006

pSivida signs $33.7m MOU to fund eye disease treatment

Perth-based biotechnology comapny pSivida Ltd has signed a $33.7 million agreement with an unnamed investment fund to finance development of the company's diabetic macular edema treatment.

20 Jun 2006

Volatile market forces WA backdown

Two Western Australian companies have cited investment market volatility as a key issue for the failure of their fund raising plans, the first notable setbacks after a period of unprecedented corporate activity.

30 May 2006

pSivida directors take up entitlements under rights issue

Directors of Perth headquartered global bio-nanotech company pSivida Ltd have confirmed that they will be taking up rights to subscribe for pSivida shares under their respective individual eligible entitlements to raise approximately $29 million.

23 May 2006

pSivida appoints Boston-based CFO & General Counsel

Bio-nanotech company pSivida Ltd has announced that Michael Soja has been appointed Vice President, Finance and Chief Financial Officer, and Lori Freedman has been appointed Vice President, Corporate Affairs, General Counsel and Secretary.

03 May 2006

pSivida to raise $29m to fund clinical trials

Perth headquartered bio-nanotech company pSivida Ltd is looking to raise $29 million through a non-renounceable rights issue to fund clinical trials for two of its treatments.

05 Apr 2006

pSivida in new evaluation agreement

Perth-based bio-nanotech company pSivida Ltd has entered into an evaluation agreement with a large medical device company to evaluate cardiovascular delivery of drugs using pSivida's drug delivery technologies.

10 Feb 2006

pSivida's Retisert to be co-promoted in the US

Shares in Western Australia's biggest biotechnology stock, pSivida Ltd, have risen 7 per cent following news that its Retisert product, licensed to Bausch & Lomb, will be co-promoted in the United States by Novartis Ophthalmics.

04 Jan 2006

pSivida acquires US drug delivery company

Nanotechnology company pSivida Ltd has acquired US drug delivery company Control Delivery Systems Inc as part of pSivida's on-going US growth strategy.

01 Dec 2005

pSivida confirms new food technology spin off

Perth biotechnology company pSivida has confirmed the creation of a new spin off, pSiNutria Ltd, a company it will seed with $1.5 million to focus on techology applying to the food industry.

18 Oct 2005

pSivida article off the money

I WOULD like to take this opportunity to distinguish pSivida from the types of problems in moving to foreign exchanges as highlighted by Tim Treadgold in Briefcase (WA Business News, October 13).

02 Aug 2005

pSivida Ltd

pSivida Ltd 26-Jul-05 29,130,677 ordinary fully paid shares will be released from escrow on 5 August 2005.

05 Apr 2005

pSivida builds UK facility

PERTH-BASED nano-technology company pSivida Limited has announced that its UK manufacturing partner, Atomising Systems Limited, has completed construction of a dedicated clean-room facility at its She

25 Jan 2005

pSivida Ltd - 20-Jan-05

1,012,302 ordinary fully paid shares will be released from voluntary escrow on 5

30 Nov 2004

pSivida takes a global perspective

Nanotechnology company pSivida has emerged this year as Western Australia's largest biotechnology stock. Mark Beyer reports on its global progress.

13 Jul 2004

pSivida leading charge

08 Jun 2004

pSivida Ltd - 02-Jun-04

01 Jun 2004

pSivida buys its UK arm

NANOTECHNOLOGY company pSivida has simplified its corporate structure by acquiring 100 per cent of its UK operating subsidiary, pSiMedica.

03 Feb 2004

Psivida Ltd

Psivida Ltd 23-Jan-04 Lodged response to ASX query.

14 Oct 2003

pSiVida gets licence

BIOSILICON company pSiVida has signed a worldwide licence agreement with its UK subsidiary, pSiMedica, for the use of BioSilicon in diagnostics applications as implants in the bodie

30 Sep 2003

pSivida clinches US patent

UK-BASED pSivida subsidiary pSiMedica has received notice of allowance of a new US patent.

30 Sep 2003

pSiVida signs into UK research agreement

PSIVIDA Limited's UK subsidiary pSiMedica has signed a research materials agreement with EpiTan Limited.

05 Feb 2002

Deals keep coming for pSivida

PERTH-BASED biotechnology company pSivida Ltd has signed its second major collaborative deal with an international university in two months.

News Articles for pSivida

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark